Firms & Funds Swander Pace gets about 8x EBITDA for Insight Pharma Steve Gelsi - September 8 2014 Share A- A+ 100% Create an account to continue reading Gain instant access to our expert editorial analysis and in-depth insight. Register for free Already have an account? Sign in
